Literature DB >> 15876873

Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype.

Francesca Ricci1, Scott E Kern, Ralph H Hruban, Christine A Iacobuzio-Donahue.   

Abstract

If there is a "science" of tumor-stromal interactions, there must be a set of biologic rules that are organ-site dependent. One way to explore this hypothesis would be to compare the patterns of gene expression of two biologically distinct neoplasms that arise within the same organ site. Using nonradioactive in situ hybridization, we evaluated the gene expression patterns of three genes previously shown to be robust markers of the juxtatumoral stroma within eight infiltrating ductal adenocarcinoma of the pancreas (ApoC1, ApoD and MMP11), and compared these patterns to those associated with seven infiltrating colloid and tubular carcinomas arising in association with intraductal papillary mucinous neoplasms (IPMNs), a histologically distinct form of primary carcinoma of the pancreas, two surgically resected samples of chronic pancreatitis and two surgically resected pancreatic cancer liver metastases. Robust juxtatumoral stromal expression was noted for all three markers within all eight conventional infiltrating ductal adenocarcinoma tissues, but not in samples of chronic pancreatitis. Among the carcinomas arising within an IPMN, expression for all three markers was also noted for five of seven infiltrating carcinomas analyzed. However, when labeling for these three markers was analyzed with respect to infiltrative growth pattern, positive labeling was only seen in areas of tubular (ductal-type) growth and not in areas of colloid carcinoma. This observation was further supported by two infiltrating carcinomas arising in an IPMN that showed both tubular and colloid growth patterns within the same neoplasm indicating the host stromal response observed may relate to infiltrative growth pattern rather than the biology of the primary tumor type. Moreover, these robust patterns within conventional infiltrating ductal adenocarcinomas were not retained within matched metastases to the liver, indicating the importance of the tumor microenvironment in the host stromal response. Juxtatumoral stroma was found to be composed of a least two cell types, tumor-infiltrating macrophages and fibroblasts, highlighting the complexity of tumor-stromal interactions within an infiltrating carcinoma. Since the juxtatumoral gene expression response is the strongest indication of direct communication between stroma and cancer cells, we provide evidence of a stereotypical response to infiltrative growth that might predominate in tumor-stromal interactions independent of cancer type, a finding with clinical implications for therapeutic modalities that target this response in human tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876873     DOI: 10.4161/cbt.4.3.1501

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  16 in total

1.  Targeted nanogels: a versatile platform for drug delivery to tumors.

Authors:  Eric A Murphy; Bharat K Majeti; Rajesh Mukthavaram; Lisette M Acevedo; Leo A Barnes; David A Cheresh
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

2.  Validation of a robust proteomic analysis carried out on formalin-fixed paraffin-embedded tissues of the pancreas obtained from mouse and human.

Authors:  Kyoko Kojima; Gregory J Bowersock; Chinatsu Kojima; Christopher A Klug; William E Grizzle; James A Mobley
Journal:  Proteomics       Date:  2012-11       Impact factor: 3.984

Review 3.  Proteome-based biomarkers in pancreatic cancer.

Authors:  Chen Sun; Ann H Rosendahl; Daniel Ansari; Roland Andersson
Journal:  World J Gastroenterol       Date:  2011-11-28       Impact factor: 5.742

4.  Pancreatic cancer associated fibroblasts display normal allelotypes.

Authors:  Kimberly Walter; Noriyuki Omura; Seung-Mo Hong; Margaret Griffith; Michael Goggins
Journal:  Cancer Biol Ther       Date:  2008-03-08       Impact factor: 4.742

5.  In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.

Authors:  Hirohiko Kamiyama; Mihoko Kamiyama; Seung-Mo Hong; Collins A Karikari; Ming-Tseh Lin; Michael W Borges; Margaret Griffith; Angela Young; Alexis Norris-Kirby; Conrad Lubek; Masamichi Mizuma; Georg Feldmann; Chanjuan Shi; Hong Liang; Michael G Goggins; Anirban Maitra; Ralph H Hruban; James R Eshleman
Journal:  Lab Invest       Date:  2010-03-15       Impact factor: 5.662

6.  Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.

Authors:  A Xue; C J Scarlett; L Chung; G Butturini; A Scarpa; R Gandy; S R Wilson; R C Baxter; R C Smith
Journal:  Br J Cancer       Date:  2010-06-29       Impact factor: 7.640

Review 7.  Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

8.  Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

Authors:  Abasi Ene-Obong; Andrew J Clear; Jennifer Watt; Jun Wang; Rewas Fatah; John C Riches; John F Marshall; Joanne Chin-Aleong; Claude Chelala; John G Gribben; Alan G Ramsay; Hemant M Kocher
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

9.  MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

Authors:  Atsuo Ochi; Andrew H Nguyen; Andrea S Bedrosian; Harry M Mushlin; Saman Zarbakhsh; Rocky Barilla; Constantinos P Zambirinis; Nina C Fallon; Adeel Rehman; Yuliya Pylayeva-Gupta; Sana Badar; Cristina H Hajdu; Alan B Frey; Dafna Bar-Sagi; George Miller
Journal:  J Exp Med       Date:  2012-08-20       Impact factor: 14.307

10.  Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling.

Authors:  Christian Pilarsky; Ole Ammerpohl; Bence Sipos; Edgar Dahl; Arndt Hartmann; Axel Wellmann; Till Braunschweig; Matthias Löhr; Ralf Jesenofsky; Ralf Jesnowski; Helmut Friess; Moritz Nicolas Wente; Glen Kristiansen; Beatrix Jahnke; Axel Denz; Felix Rückert; Hans K Schackert; Günter Klöppel; Holger Kalthoff; Hans Detlev Saeger; Robert Grützmann
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.